Eli Lilly, Novo Nordisk Antitrust Suit Remains Dismissed

By Rae Ann Varona · October 23, 2026, 10:14 PM EDT

A Texas federal judge has denied Strive Specialties Inc.'s bid to undo her judgment dismissing the compounding pharmacy's lawsuit that accuses Eli Lilly and Novo Nordisk of blocking competition for GLP-1...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Strive Specialties, Inc. v. Eli Lilly & Company et al

Case Number

5:26-cv-00155

Court

Texas Western

Nature of Suit

Anti-Trust

Date Filed

January 14, 2026